Luther W Brady

Radiotherapy's second setback

Luther W Brady, William E. Powers, L. Brady, 1989, BMJ.

Radioimmunotherapy as a novel treatment regimen: 125I-labeled monoclonal antibody 425 in the treatment of high-grade brain gliomas.

Luther W Brady, L. Brady, Tony S Quang, 2004, International journal of radiation oncology, biology, physics.

Red shell: defining a high-risk zone of normal tissue damage in stereotactic body radiation therapy.

Luther W Brady, J. Fowler, L. Brady, 2010, International journal of radiation oncology, biology, physics.